MMJ Observer
Tag Archives: OTCMKTS:CBIS
Cannabis Science Inc

Cannabis Science Inc (OTCMKTS:CBIS) a U.S. firm specializing in the advancement of cannabis-based medicines will submit an offering memorandum worth $25 million to accommodate an aggressive expansion strategy; the firm projects to submit next...

By Jaime Williams on Apr 13th, 2017

Cannabis Science Inc (OTCMKTS:CBIS)  has announced the appointment of Julia Royall as a new member of its scientific advisory board. Royall is a renowned and experienced leader in health information. Royall is a long time specialized consultant...

By Emily Gibson on Apr 5th, 2017
Cannabis Science Inc

Cannabis Science Inc (OTCMKTS:CBIS) a U.S. firm specializing in the advancement of cannabis-based drugs reported the anticipated delivery of the first of its pre-designed greenhouses with reporting and tracking protocols to be offered this week...

By Steven Russell on Mar 23rd, 2017
Cannabis Science Inc

Cannabis Science Inc (OTCMKTS:CBIS) a U.S. firm specializing in the advancement of cannabis-based drugs announced the anticipated delivery of its first pre-designed greenhouses with tracking and reporting protocols available for delivery this...

By Elizabeth Jackson on Mar 14th, 2017
Cannabis Science Inc

Cannabis Science Inc (OTCMKTS:CBIS) a U.S. firm specializing in the advancement of cannabis-based medicines, released updates on the planned self-administering DPI Inhalation Device for COPD/ Asthma and their CBD infused pain patch. The firm...

By Steven Russell on Feb 28th, 2017
Cannabis Science Inc

The injection of modern know-how into the evolving world of legal medical marijuana and cannabis is helping the industry scale new heights and increase interaction with clients, mainly when it comes to cannabis subjects in the medical aspect...